Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.

Tremmel E, Hofmann S, Kuhn C, Heidegger H, Heublein S, Hermelink K, Wuerstlein R, Harbeck N, Mayr D, Mahner S, Ditsch N, Jeschke U, Vattai A.

Breast Cancer (Dove Med Press). 2019 Feb 19;11:87-97. doi: 10.2147/BCTT.S178721. eCollection 2019.

2.

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.

Heublein S, Page S, Mayr D, Schmoeckel E, Trillsch F, Marmé F, Mahner S, Jeschke U, Vattai A.

Int J Mol Sci. 2019 Jan 12;20(2). pii: E295. doi: 10.3390/ijms20020295.

3.

TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.

Heublein S, Friese K, Kost B, Marmé F, Kuhn C, Mahner S, Dannecker C, Mayr D, Jeschke U, Vattai A.

J Cancer Res Clin Oncol. 2018 Oct;144(10):1899-1907. doi: 10.1007/s00432-018-2706-5. Epub 2018 Jul 30.

PMID:
30062487
4.

PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas.

Kolben TM, Rogatsch E, Vattai A, Hester A, Kuhn C, Schmoeckel E, Mahner S, Jeschke U, Kolben T.

Int J Mol Sci. 2018 Jun 26;19(7). pii: E1872. doi: 10.3390/ijms19071872.

5.

Prostaglandin E2 receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses.

Ye Y, Vattai A, Ditsch N, Kuhn C, Rahmeh M, Mahner S, Ripphahn M, Immler R, Sperandio M, Jeschke U, von Schönfeldt V.

Endocr Connect. 2018 May;7(5):749-761. doi: 10.1530/EC-18-0106. Epub 2018 Apr 26.

6.

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages.

Gratz MJ, Stavrou S, Kuhn C, Hofmann S, Hermelink K, Heidegger H, Hutter S, Mayr D, Mahner S, Jeschke U, Vattai A.

Endocr Connect. 2018 May;7(5):727-738. doi: 10.1530/EC-18-0126. Epub 2018 Apr 23.

7.

TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC.

Stavrou S, Gratz M, Tremmel E, Kuhn C, Hofmann S, Heidegger H, Peryanova M, Hermelink K, Hutter S, Toth B, Mayr D, Mahner S, Jeschke U, Vattai A.

Endocr Connect. 2018 Feb;7(2):372-384. doi: 10.1530/EC-17-0272.

8.

Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.

Vattai A, Cavailles V, Sixou S, Beyer S, Kuhn C, Peryanova M, Heidegger H, Hermelink K, Mayr D, Mahner S, Dannecker C, Jeschke U, Kost B.

Oncotarget. 2017 Oct 31;8(62):105356-105371. doi: 10.18632/oncotarget.22187. eCollection 2017 Dec 1.

9.

Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders.

Knabl J, Vattai A, Ye Y, Jueckstock J, Hutter S, Kainer F, Mahner S, Jeschke U.

Int J Mol Sci. 2017 Nov 6;18(11). pii: E2340. doi: 10.3390/ijms18112340. Review.

10.

The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.

Friese K, Kost B, Vattai A, Marmé F, Kuhn C, Mahner S, Dannecker C, Jeschke U, Heublein S.

J Cancer Res Clin Oncol. 2018 Jan;144(1):13-19. doi: 10.1007/s00432-017-2510-7. Epub 2017 Sep 18.

PMID:
28924735
11.

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Ye Y, Vattai A, Zhang X, Zhu J, Thaler CJ, Mahner S, Jeschke U, von Schönfeldt V.

Int J Mol Sci. 2017 Jul 29;18(8). pii: E1651. doi: 10.3390/ijms18081651. Review.

12.

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.

Heidegger H, Dietlmeier S, Ye Y, Kuhn C, Vattai A, Aberl C, Jeschke U, Mahner S, Kost B.

Int J Mol Sci. 2017 Jul 19;18(7). pii: E1571. doi: 10.3390/ijms18071571.

13.

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Vattai A, Akyol E, Kuhn C, Hofmann S, Heidegger H, von Koch F, Hermelink K, Wuerstlein R, Harbeck N, Mayr D, Spitzweg C, Toth B, Mahner S, Jeschke U, Ditsch N.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1637-1647. doi: 10.1007/s00432-017-2420-8. Epub 2017 Apr 13.

PMID:
28409272
14.

Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.

Weber M, Göhner C, San Martin S, Vattai A, Hutter S, Parraga M, Jeschke U, Schleussner E, Markert UR, Fitzgerald JS.

Cell Adh Migr. 2016 Mar 3;10(1-2):56-65. doi: 10.1080/19336918.2016.1142035. Epub 2016 Feb 25.

15.

The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitro.

Vattai A, Ziegelmüller B, Kost B, Kuhn C, Hofmann S, Bayer B, Anslinger K, Jeschke U, Ditsch N.

Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:31-9. doi: 10.1016/j.ejogrb.2015.09.003. Epub 2015 Sep 30.

PMID:
26476797
16.

Expression of Thyroid Hormone Receptors in Villous Trophoblasts and Decidual Tissue at Protein and mRNA Levels Is Downregulated in Spontaneous and Recurrent Miscarriages.

Ziegelmüller B, Vattai A, Kost B, Kuhn C, Hofmann S, Bayer B, Toth B, Jeschke U, Ditsch N.

J Histochem Cytochem. 2015 Jul;63(7):511-23. doi: 10.1369/0022155415582052. Epub 2015 Mar 26.

PMID:
25814482

Supplemental Content

Loading ...
Support Center